4//SEC Filing
STERIS CORP 4
Accession 0001209191-15-077688
CIK 0000815065operating
Filed
Nov 1, 7:00 PM ET
Accepted
Nov 2, 4:08 PM ET
Size
28.4 KB
Accession
0001209191-15-077688
Insider Transaction Report
Form 4
STERIS CORPSTE
Zangerle John Adam
VP, Gen Counsel, and Sec.
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−3,100→ 0 totalExercise: $30.84Exp: 2018-05-21→ Common Shares, No Par Value (3,100 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−3,150→ 0 totalExercise: $22.83Exp: 2019-05-21→ Common Shares, No Par Value (3,150 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−3,500→ 0 totalExercise: $36.09Exp: 2021-05-31→ Common Shares, No Par Value (3,500 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−3,800→ 0 totalExercise: $29.94Exp: 2022-05-30→ Common Shares, No Par Value (3,800 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−3,000→ 0 totalExercise: $31.87Exp: 2020-05-20→ Common Shares, No Par Value (3,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−12,252→ 0 totalExercise: $53.52Exp: 2024-05-30→ Common Shares, No Par Value (12,252 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−8,000→ 0 totalExercise: $67.98Exp: 2025-08-10→ Common Shares, No Par Value (8,000 underlying) - Disposition to Issuer
Common Shares, No Par Value
2015-11-02−18,608→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−2,200→ 0 totalExercise: $27.68Exp: 2017-07-27→ Common Shares, No Par Value (2,200 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2015-11-02−6,000→ 0 totalExercise: $45.34Exp: 2023-05-31→ Common Shares, No Par Value (6,000 underlying)
Footnotes (11)
- [F1]13,652 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 1,400 on May 31, 2016; 1,000 on August 1, 2016; 1,000 on November 28, 2016; 5,000 on May 31, 2017; 2,252 on May 30, 2018; and 3,000 on May 28, 2019.
- [F10]This option becomes exercisable as follows: 3,063 on May 30, 2016; 3,063 on May 30, 2017 and 3,063 on May 30, 2018. This option was assumed by New STERIS in the Merger and converted to an option to purchase 12,252 ordinary shares of New STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F11]This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by New STERIS in the Merger and converted to an option to purchase 8,000 ordinary shares of New STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F2]Represents shares of STERIS Corporation ("STERIS") disposed of pursuant to merger of a wholly-owned subsidiary of STERIS plc ("New STERIS") with and into STERIS, with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for ordinary shares of New STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share.
- [F3]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 2,200 ordinary shares of New STERIS for $27.68 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F4]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,100 ordinary shares of New STERIS for $30.84 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F5]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,150 ordinary shares of New STERIS for $22.83 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F6]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,000 ordinary shares of New STERIS for $31.87 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F7]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,500 ordinary shares of New STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F8]This option becomes exercisable as follows: 950 on May 30, 2016. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,800 ordinary shares of New STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F9]This option becomes exercisable as follows: 1,500 on May 31, 2016 and 1,500 on May 31, 2017. This option was assumed by New STERIS in the Merger and converted to an option to purchase 6,000 ordinary shares of New STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
Documents
Issuer
STERIS CORP
CIK 0000815065
Entity typeoperating
IncorporatedOH
Related Parties
1- filerCIK 0000815065
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 7:00 PM ET
- Accepted
- Nov 2, 4:08 PM ET
- Size
- 28.4 KB